Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FW4AQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,897
Award facts
- Contract value 100% obligated
- $50,896.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $50,896.94 for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and other supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in meeting Defense Logistics Agency procurement requirements for military and veteran healthcare systems, with particular expertise in delivering specialty pharmaceuticals such as diabetes medications, neurological treatments, and pain management products through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DB25FW4AQ?
SPE2DB25FW4AQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FW4AQ worth?
The government has obligated $50,897 on SPE2DB25FW4AQ.
Is contract SPE2DB25FW4AQ an order under another contract?
Yes. SPE2DB25FW4AQ is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW4AQ competed?
The extent of competition for SPE2DB25FW4AQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award